About Kerecis
Kerecis is a company based in Isafjordur (Iceland) founded in 2007 was acquired by Coloplast in July 2023.. Kerecis has raised $93.11 million across 14 funding rounds from investors including SVB, Coloplast and European Union. The company has 150 employees as of December 31, 2021. Kerecis has completed 1 acquisition, including Phytoceuticals. Kerecis offers products and services including MariGen, SurgiClose, SurgiBind, GraftGuide, and Shield. Kerecis operates in a competitive market with competitors including BONESUPPORT, Sofregen, Lamellar, Arsenal Medical and Cerapedics, among others.
- Headquarter Isafjordur, Iceland
- Employees 150 as on 31 Dec, 2021
- Stage Minicorn
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Kerecis, Llc
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Kerecis
Kerecis offers a comprehensive portfolio of products and services, including MariGen, SurgiClose, SurgiBind, GraftGuide, and Shield. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Fish skin graft for treating chronic wounds and ulcers.
Combination graft for soft-tissue repair in trauma.
Product for burn wound healing and regeneration.
Guide for applying fish skin in surgical procedures.
Fish skin product for private office wound care.
Solutions for animal wound treatment and healing.
Unlock access to complete
Sales and Marketing
38 people
Leadership Team
28 people
Regenerative Team
23 people
Software Development Team
11 people
Product Management Team
11 people
Finance and Accounting
6 people
Human Resources and Administration
2 people
Senior Team
2 people
Unlock access to complete
Funding Insights of Kerecis
Kerecis has successfully raised a total of $93.11M across 14 strategic funding rounds. The most recent funding activity was a Series D round of $30 million completed in July 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 14
- Last Round Series D — $30.0M
- First Round First Round
- Investors Count 7
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2022 | Amount | Debt – Venture - Kerecis | Valuation |
investors |
|
| Jul, 2022 | Amount | Series D - Kerecis | Valuation | KIRKBI A/S | |
| Jun, 2022 | Amount | Series C - Kerecis | Valuation | KIRKBI A/S |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Kerecis
Kerecis has secured backing from 8 investors, including institutional and venture fund investors. Prominent investors backing the company include SVB, Coloplast and European Union. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
KIRKBI is engaged in building a better future for children.
|
Founded Year | Domain | Location | |
|
A venture capital fund focused on supporting innovative startups in Iceland.
|
Founded Year | Domain | Location | |
|
Banking services are provided to innovative companies, investors, and individuals.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Kerecis
Kerecis has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Phytoceuticals. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Wound healing products are manufactured by Phytoceuticals in Switzerland.
|
2015 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - Kerecis
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Kerecis Comparisons
Competitors of Kerecis
Kerecis operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as BONESUPPORT, Sofregen, Lamellar, Arsenal Medical and Cerapedics, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Injectable synthetic bone substitutes are developed for fracture treatment.
|
|
| domain | founded_year | HQ Location |
Silk-derived biomaterials are developed for soft tissue repair in surgery.
|
|
| domain | founded_year | HQ Location |
Develops patented medical devices and pharmaceuticals based on mimetics of extra-alveolar lamellar bodies
|
|
| domain | founded_year | HQ Location |
Polymer-based foams and fibers are developed for medical applications.
|
|
| domain | founded_year | HQ Location |
Osteobiologic products are developed using synthetic peptide technology.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about Kerecis
When was Kerecis founded?
Kerecis was founded in 2007 and raised its 1st funding round 3 years after it was founded.
Where is Kerecis located?
Kerecis is headquartered in Isafjordur, Iceland.
Is Kerecis a funded company?
Kerecis is a funded company, having raised a total of $93.11M across 14 funding rounds to date. The company's 1st funding round was a Series C of $40M, raised on Jan 05, 2010.
How many employees does Kerecis have?
As of Dec 31, 2021, the latest employee count at Kerecis is 150.
What does Kerecis do?
Founded in 2007 in Isafjordur, Iceland, the company operates in the medical technology sector, focusing on acellular fish-skin grafts. Omega3 technology is utilized in products for chronic wound management, hernia repair, breast reconstruction, and abdominal wall reconstruction. Advantages over human and porcine alternatives include better economics, enhanced clinical outcomes, lower disease transmission risks, and no cultural usage barriers. The domain kerecis.com supports global operations.
Who are the top competitors of Kerecis?
Kerecis's top competitors include BONESUPPORT, Kitotech Medical and Cerapedics.
What products or services does Kerecis offer?
Kerecis offers MariGen, SurgiClose, SurgiBind, GraftGuide, and 2 more products and services.
How many acquisitions has Kerecis made?
Kerecis has made 1 acquisition, including Phytoceuticals.
Who are Kerecis's investors?
Kerecis has 8 investors. Key investors include SVB, Coloplast, European Union, KIRKBI, and LSR.
What is Kerecis's valuation?
The valuation of Kerecis is $620M as of Jul 2022.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.